Munich - Delayed Quote • EUR
Iovance Biotherapeutics Inc (2LB.MU)
At close: April 26 at 8:03 AM GMT+2
Growth Estimates
| CURRENCY IN USD | 2LB.MU | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | -- |
| Next Qtr. | -- | -- | -- | -- |
| Current Year | -- | -- | -- | -- |
| Next Year | -- | -- | -- | -- |
| Next 5 Years (per annum) | -- | -- | -- | -- |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
| Maintains | Piper Sandler: Overweight to Overweight | 3/14/2024 |
| Maintains | Truist Securities: Buy to Buy | 3/7/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/4/2024 |
| Maintains | Wells Fargo: Overweight to Overweight | 3/1/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/29/2024 |
| Maintains | Goldman Sachs: Buy to Buy | 2/29/2024 |